ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1363 • 2015 ACR/ARHP Annual Meeting

    Changes in Cyclooxygenase-2’s Expression, and PGE2’s and 6-Keto-PGF1α Levels in the Presence of the Muscarinic Acethylcholine Receptor Antibody in Primary Sjogren Syndrome

    Micaela Ana Cosatti1, Silvia Reina2, Cecilia N. Pisoni3, Alicia Eimon4, Sabrina Ganzinelli2 and Enri Borda2, 1Section Rheumatology and Immunology, CEMIC, CABA, Argentina, 2Pharmacology Unit, School of Dentistry, University of Buenos Aires, Buenos Aires, Argentina; National Research Council of Argentina (CONICET), Buenos Aires, Argentina, 3Lupus Research Unit, The Rayne Institute, St Thomas' Hospital and Kings College London, London, United Kingdom, 4CEMIC, Buenos Aires, Argentina

    Background/Purpose: to assess the inflammatory process provoked by the M3 muscarinic acetylcholine receptor antibody from primary Sjogren Syndrome (pSS) patient’s sera in rat submandibular gland…
  • Abstract Number: 1364 • 2015 ACR/ARHP Annual Meeting

    Treating Experimental Arthritis with the Innate Immune Inhibitor IL-37 Reduces Joint and Systemic Inflammation

    Giulio Cavalli1, Marije Koenders2, Lorenzo Dagna3, Alberto Mantovani4, Cecilia Garlanda4, Leo Joosten5 and Charles Dinarello1, 1Department of Medicine, Division of Infectious Diseases, University of Colorado, Denver, CO, 2Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 3Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milano, Italy, 4Research Institute Humanitas, Milan, Italy, 5Internal Medicine, Radboud university medical center, Nijmegen, Netherlands

    Background/Purpose: Characterized as a fundamental inhibitor of innate inflammation, IL‑1 family member IL‑37 is expressed in the synovia of patients with rheumatoid arthritis. We investigated…
  • Abstract Number: 1365 • 2015 ACR/ARHP Annual Meeting

    Innate Lymphoid Cells. New Players in Systemic Sclerosis Correlate with Extent of Skin and Lung Fibrosis

    Thomas Wohlfahrt1, Stefanie Weber1, Matthias Englbrecht2, Clara Dees3, Christian Beyer3, Oliver Distler4, Georg Schett1, Jorg HW Distler1,3 and Andreas Ramming1, 1Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Department of Internal Medicine 3, Rheumatology & Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 3Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 4Research of Systemic Autoimmune Diseases, Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland

    Background/Purpose: Type 2 innate lymphoid cells (ILC2s), are recently identified as population of cells with lymphoid morphology lacking re-arranged antigen-specific receptors. Although findings in animal…
  • Abstract Number: 1366 • 2015 ACR/ARHP Annual Meeting

    Natural Antibodies, Not B Cells, Contribute to Acute Cell Death-Induced Inflammation

    Hiroshi Kataoka, Rheumatology and Clinical Immunology, Sapporo City General Hospital, Sapporo, Japan

    Background/Purpose: Alarmins, such as uric acid, released from dying cells activate inflammasomes and mediate dead cell-induced inflammation (Ref.). Since it is remains unknown whether or…
  • Abstract Number: 1367 • 2015 ACR/ARHP Annual Meeting

    Fibroblast-like Synoviocytes Shape and Perpetuate the Inflammatory Immune Responses Associated with Antibiotic-Refractory Lyme Arthritis.

    Klemen Strle1, Robert Locchead2, Annalisa Pianta3, Jameson T. Crowley3, Sheila Arvikar1 and John Aversa4, 1Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Rheumatology, Allery and Immunology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 3Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Yale Medical Group, Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, CT

    Background/Purpose: Antibiotic-refractory Lyme arthritis is defined as persistent synovitis for months to years after antibiotic therapy for Borrelia burgdorferi, the causative agent of Lyme disease.…
  • Abstract Number: 1368 • 2015 ACR/ARHP Annual Meeting

    PMN Reactivity Contribute to Acute Onset Joint Inflammation By Increasing CXCL8 Production in Joints of RA Patients with Anti-Collagen II Antibodies

    Vivek Anand Manivel1, Azita Sohrabian2 and Johan Rönnelid3,4, 1Immunology, Genetics and Pathology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, 2Department of Immunology Genetics and Pathology,Uppsala University, Uppsala, Sweden, 3Department of Immunology, Genetics and Pathology,Uppsala University, Uppsala, Sweden, 44Unit of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: RA patients with antibodies against collagen type II (CII) have a distinct acute onset RA phenotype, associated with cytokine induction by surface-bound anti-CII IC…
  • Abstract Number: 1369 • 2015 ACR/ARHP Annual Meeting

    Enhanced Myelopoiesis Downstream of Toll-like Receptor 9 Activation Drives a Feed-Forward Inflammatory Response

    Lehn K. Weaver1 and Edward M. Behrens2, 1Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 2Pediatric Rheumatology, Childrens Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Monocytes are myeloid cells important for the initiation of inflammation and have been implicated in the pathogenesis of autoimmunity. Monocytes interact with their environment…
  • Abstract Number: 1370 • 2015 ACR/ARHP Annual Meeting

    CD40/CD40L Pathway Is Associated with Increased Oxidative Burst and Neutrophil Extracellular Traps Release in Behcet´s Disease

    Sandro F. Perazzio1,2, Paulo Vitor Soeiro Pereira3, Alexandre W.S. Souza4, Antonio Condino-Neto3 and Luis Eduardo C. Andrade5, 1Rheumatology Division, Universidade Federal de São Paulo, Sao Paulo, Brazil, 2Fleury Medicine and Health, Sao Paulo, Brazil, 3Immunology, ICB IV - Universidade de São Paulo, São Paulo, Brazil, 4Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 5Immunology Division, Fleury Medicine and Health, São Paulo, Brazil

    Background/Purpose: Previous studies suggested that unknown plasma factors increase oxidative burst in Behçet’s disease (BD), but little is known about neutrophil extracellular traps (NET) formation.…
  • Abstract Number: 1371 • 2015 ACR/ARHP Annual Meeting

    Complement-Mediated Neutrophil Lysis-a Mechanism Promoting Hypercitrullination in Rheumatoid Arthritis?  

    Tal Gazitt1, Christian Lood2, Jeffrey Ledbetter3 and Keith B. Elkon3, 1Rheumatology, University of Washington, Seattle, WA, 2University of Washington, Lund, Sweden, 3Division of Rheumatology, University of Washington, Seattle, WA

    Background/Purpose: Protein citrullination, the post-translational conversion of arginine to citrulline, mediated by peptidylarginine deiminase (PAD) enzymes, is considered a likely mechanism for the stimulation of…
  • Abstract Number: 1372 • 2015 ACR/ARHP Annual Meeting

    Characterization of Synovial Mast Cells in Knee Osteoarthritis: Association with Clinical Parameters

    Badelog J.E. de Lange-Brokaar1, Margreet Kloppenburg1, Stefan Andersen1, Annemarie Dorjee1, Erlangga Yusuf1, Linda van Toorn1, Herman Kroon2, Anne-Marie Zuurmond3, Vedrana Stojanovic-Susulic4, Johan Bloem2, Rob Nelissen5, René E. M. Toes6 and Andreea Ioan-Facsinay1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, Leiden University Medical Center, Leiden, Netherlands, 3TNO, Leiden, Netherlands, 4Janssen, Pharmaceutical Companies Johnson & Johnson, Springhouse, PA, 5Orthopaedics, Leiden University Medical Center, Leiden, Netherlands, 6Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Synovial inflammation is a common feature of osteoarthritis (OA) and rheumatoid arthritis (RA) patients. Comparative studies indicated that synovitis, measured by histology or imaging,…
  • Abstract Number: 1373 • 2015 ACR/ARHP Annual Meeting

    Epigenetic Mechanisms Contribute to the Lack of LPS-Induced Tolerance in Rheumatoid Arthritis Synovial Fibroblasts

    Kerstin Klein1, Renate E. Gay1, Christoph Kolling2, Adrian Ciurea1, Diego Kyburz1, Beat A. Michel1, Lih-Ling Lin3, Steffen Gay1 and Caroline Ospelt1, 1Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Upper Extremity Dept., Schulthess Clinic Zurich, Zurich, Switzerland, 3Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA

    Background/Purpose: In macrophages, repeated stimulation of Toll-like receptor (TLR) 4 leads to a tolerant state of the cell which protects inflamed tissues from damage. We…
  • Abstract Number: 1374 • 2015 ACR/ARHP Annual Meeting

    Mucosal-Associated Invariant T- Cells Are Decreased and Functionally Immature in Peripheral Blood of Patients with Primary Sjögren Syndrome

    Tatjana Banovic1,2,3, Jing Jing Wang4, Dimitra Beroukas5, Pravin Hissaria6 and Tom Gordon2,6, 1Immunology, Level 3, SA Pathology, Adelaide, Australia, 2Flinders University, Adelaide, Australia, 3Pediatrics, University of Adelaide, Adelaide, Australia, 4Immunology, Flinders University, Adelaide, Australia, 5SA Pathology, Adelaide, Australia, 6Immunology, SA Pathology, Adelaide, Australia

    Background/Purpose: Primary Sjögren Syndrome (pSS) is characterized by organ-specific autoimmune destruction of salivary and lacrimal glands. Patients typically experience debilitating symptoms of dry mouth and…
  • Abstract Number: 1375 • 2015 ACR/ARHP Annual Meeting

    S100A8/A9, a Serum and Imaging Biomarker for Assessing Joint Inflammation and Destruction in Experimental Seronegative Arthritis

    Edwin J. W. Geven1, Shahla Abdolahi-Roodsaz1, Annet Sloetjes1, Marije I. Koenders1, Dirk Föll2, Johannes Roth3, Thomas Vogl3 and Peter L. E. M. van Lent1, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 2Department of Pediatric Rheumatology and Immunology, University of Münster, Münster, Germany, 3Institute of Immunology, University of Münster, Münster, Germany

    Background/Purpose: Seronegative joint diseases such as psoriatic arthritis and juvenile idiopathic arthritis are characterized by the lack of autoantibodies, potent biomarkers used for predicting disease…
  • Abstract Number: 1376 • 2015 ACR/ARHP Annual Meeting

    Presence of the Interferon Signature in Anti-Nuclear Antibody Positive Individuals Prior to the Onset of Systemic Autoimmune Rheumatic Disease

    Joan Wither1, Tony Liu1, Babak Noamani2, Dennisse Bonilla1, Sindhu R. Johnson3, Earl Silverman4, Arthur Bookman1, Larissa Lisnevskaia5 and Carolina Landolt-Marticorena1, 1University Health Network, Toronto, ON, Canada, 2Genetics and developmental biology, University Health Network, Toronto, ON, Canada, 3Toronto Scleroderma Program, Toronto Western Hospital, Mount Sinai Hospital, University of Toronto, University Health Network Pulmonary Hypertension Programme, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, ON, Canada, 5Lakeridge Health Services, Oshawa, ON, Canada

    Background/Purpose: Patients with systemic autoimmune rheumatic diseases (SARD) often have a prolonged pre-clinical phase during which they are anti-nuclear antibody (ANA)+ but lack clinical symptoms. …
  • Abstract Number: 1377 • 2015 ACR/ARHP Annual Meeting

    IL-22 Drives the Proliferation and Differentiation of Human Bone Marrow Mesenchymal Stem Cells (MSCs); A Novel Pathway That May Contribute to Aberrant New Bone Formation in Human Spa and Beyond

    Yasser El-Sherbiny1, Ahmed Elzayadi2, Evangelos M. Fragkakis1, Richard Cuthbert1, Thomas Baboolal3, Elena Jones1 and Dennis McGonagle1, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2Obstetrics and Gynaecology, Mansoura University, Egypt, MD, MSc., Mansoura, Egypt, 3PhD, Leeds, United Kingdom

    Background/Purpose: The human spondyloarthropathies (SpA) are associated with single nucleotide polymorphisms (SNPs) in the IL-23 pathway and IL-23/17 axis therapy is effective in SpA.  The…
  • « Previous Page
  • 1
  • …
  • 1778
  • 1779
  • 1780
  • 1781
  • 1782
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology